Faes Farma SAReg Forecast, price target & analysts
Faes Farma SAReg Target price 2026 - Analyst rating & recommendation
Faes Farma SAReg Classifications & Recommendation
Faes Farma SAReg Price Target
| Target Price | €5.51 |
| Price | €4.77 |
| Potential |
15.47%
register free of charge
|
| Number of Estimates | 7 |
|
7 Analysts have issued a price target Faes Farma SAReg 2027 .
The average Faes Farma SAReg target price is €5.51.
This is
15.47%
register free of charge
€6.30
32.08%
register free of charge
€4.87
2.06%
register free of charge
|
|
| A rating was issued by 10 analysts: 7 Analysts recommend Faes Farma SAReg to buy, 3 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Faes Farma SAReg stock has an average upside potential 2027 of
15.47%
register free of charge
|
Sales and Margin forecast 2026, 2027 & 2028
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Million € | 610.46 | 747.73 |
| 23.66% | 22.49% | |
| EBITDA Margin | 19.26% | 21.39% |
| 26.21% | 11.05% | |
| Net Margin | 13.04% | 14.09% |
| 42.18% | 8.02% |
7 Analysts have issued a sales forecast Faes Farma SAReg 2026 . The average Faes Farma SAReg sales estimate is
This results in the following potential growth metrics:
7 Analysts have issued an Faes Farma SAReg EBITDA forecast 2026. The average Faes Farma SAReg EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
7 Faes Farma SAReg Analysts have issued a net profit forecast 2026. The average Faes Farma SAReg net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 & 2028
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share € | 0.25 | 0.34 |
| 30.56% | 36.00% | |
| P/E | 14.10 | |
| EV/Sales | 2.30 |
7 Analysts have issued a Faes Farma SAReg forecast for earnings per share. The average Faes Farma SAReg EPS is
This results in the following potential growth metrics and future valuations:
Faes Farma SAReg...
Current Faes Farma SAReg Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| BANCO SANTANDER |
Locked
➜
Locked
|
Locked | Aug 01 2026 |
| ODDO BHF |
Locked
➜
Locked
|
Locked | Jul 31 2026 |
| KUTXABANK INVESTMENT |
Locked
➜
Locked
|
Locked | Jul 23 2026 |
| ODDO BHF |
Locked
➜
Locked
|
Locked | Jun 25 2026 |
| ODDO BHF |
Locked
➜
Locked
|
Locked | Jun 24 2026 |
| BAADER EUROPE / ALPHAVALUE |
Locked
➜
Locked
|
Locked | Jun 08 2026 |
| BAADER EUROPE / ALPHAVALUE |
Locked
➜
Locked
|
Locked | Jun 07 2026 |
| Analyst Rating | Date |
|---|---|
|
Locked
BANCO SANTANDER:
Locked
➜
Locked
|
Aug 01 2026 |
|
Locked
ODDO BHF:
Locked
➜
Locked
|
Jul 31 2026 |
|
Locked
KUTXABANK INVESTMENT:
Locked
➜
Locked
|
Jul 23 2026 |
|
Locked
ODDO BHF:
Locked
➜
Locked
|
Jun 25 2026 |
|
Locked
ODDO BHF:
Locked
➜
Locked
|
Jun 24 2026 |
|
Locked
BAADER EUROPE / ALPHAVALUE:
Locked
➜
Locked
|
Jun 08 2026 |
|
Locked
BAADER EUROPE / ALPHAVALUE:
Locked
➜
Locked
|
Jun 07 2026 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
